1-20 of 33
Johnny Ludvigsson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial

Ida M. Mynarek, Lars Krogvold, Freja B. Mørk, Trine W.H. Lawaetz, Trine Roald, Morten W. Fagerland, Nina Lindblom, Jacob Westman, Peter Barker, Heikki Hyöty, Johnny Ludvigsson, Kristian F. Hanssen, Jesper Johannesen, Knut Dahl-Jørgensen
Journal: Diabetes Care
Diabetes Care 2025;48(3):481–488
https://doi.org/10.2337/dc24-2121
Published: 13 January 2025
View articletitled, Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial
Open the PDF for Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial in another window
Journal Articles

Family History of Diabetes and Clinical Characteristics in Children at Diagnosis of Type 1 Diabetes—A Swedish Population-Based Study

Emma Hedlund, Jasaman Tojjar, Lisa Lilja, Helena Elding Larsson, Gun Forsander, Johnny Ludvigsson, Claude Marcus, Fredrik Norström, Martina Persson, Annelie Carlsson
Journal: Diabetes Care
Diabetes Care 2024;47(11):2012–2016
https://doi.org/10.2337/dc24-0534
Published: 20 September 2024
View articletitled, Family History of Diabetes and Clinical Characteristics in Children at Diagnosis of Type 1 Diabetes—A Swedish Population-Based Study
Open the PDF for Family History of Diabetes and Clinical Characteristics in Children at Diagnosis of Type 1 Diabetes—A Swedish Population-Based Study in another window
Journal Articles

Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes: Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children

Marie Lindgren, Fredrik Norström, Martina Persson, Helena Elding Larsson, Gun Forsander, Karin Åkesson, Ulf Samuelsson, Johnny Ludvigsson, Annelie Carlsson
Journal: Diabetes Care
Diabetes Care 2024;47(4):756–760
https://doi.org/10.2337/dc23-1671
Published: 16 February 2024
View articletitled, Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes: Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children
Open the PDF for Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes: Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children in another window
Journal Articles

Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes

Jasaman Tojjar, Matti Cervin, Emma Hedlund, Qefsere Brahimi, Gun Forsander, Helena Elding Larsson, Johnny Ludvigsson, Ulf Samuelsson, Claude Marcus, Martina Persson, Annelie Carlsson
Journal: Diabetes Care
Diabetes Care 2023;46(11):1993–1996
https://doi.org/10.2337/dc23-0124
Published: 12 September 2023
View articletitled, Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes
Open the PDF for Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes in another window
Journal Articles

Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden

Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Journal: Diabetes Care
Diabetes Care 2023;46(3):570–578
https://doi.org/10.2337/dc22-1760
Published: 06 January 2023
View articletitled, Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden
Open the PDF for Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden in another window
Journal Articles

Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study

Hans J. Arnqvist, Malin C. Westerlund, Mats Fredrikson, Johnny Ludvigsson, Maria Nordwall
Journal: Diabetes Care
Diabetes Care 2022;45(11):2675–2682
https://doi.org/10.2337/dc22-0239
Published: 12 September 2022
View articletitled, Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study
Open the PDF for Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study in another window
Journal Articles

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial

Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A. Martínez-Brocca, Marisol Ruiz de Adana, Jeanette Wahlberg, Anastasia Katsarou, Ragnar Hanas, Cristina Hernandez, Maria Clemente León, Ana Gómez-Gila, Marcus Lind, Marta Ferrer Lozano, Theo Sas, Ulf Samuelsson, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Anders Nordlund, Ulf Hannelius, Rosaura Casas
Journal: Diabetes Care
Diabetes Care 2021;44(7):1604–1612
https://doi.org/10.2337/dc21-0318
Published: 21 May 2021
View articletitled, Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Open the PDF for Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial in another window
Journal Articles

Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study

Annelie Carlsson, Maggie Shepherd, Sian Ellard, Michael Weedon, Åke Lernmark, Gun Forsander, Kevin Colclough, Qefsere Brahimi, Camilla Valtonen-Andre, Sten A. Ivarsson, Helena Elding Larsson, Ulf Samuelsson, Eva Örtqvist, Leif Groop, Johnny Ludvigsson, Claude Marcus, Andrew T. Hattersley
Journal: Diabetes Care
Diabetes Care 2020;43(1):82–89
https://doi.org/10.2337/dc19-0747
Published: 12 December 2019
View articletitled, Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study
Open the PDF for Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study in another window
Includes: Supplementary data
Journal Articles

Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study

Maria Nordwall, Mats Fredriksson, Johnny Ludvigsson, Hans J. Arnqvist
Journal: Diabetes Care
Diabetes Care 2019;42(4):609–616
https://doi.org/10.2337/dc18-1950
Published: 31 January 2019
View articletitled, Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study
Open the PDF for Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study in another window
Includes: Supplementary data
Journal Articles

Increasing Incidence but Decreasing Awareness of Type 1 Diabetes in Sweden

Johnny Ludvigsson
Journal: Diabetes Care
Diabetes Care 2017;40(10):e143–e144
https://doi.org/10.2337/dc17-1175
Published: 07 August 2017
View articletitled, Increasing Incidence but Decreasing Awareness of Type 1 Diabetes in Sweden
Open the PDF for Increasing Incidence but Decreasing Awareness of Type 1 Diabetes in Sweden in another window
Journal Articles

Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315

Maria Nordwall, Mariann Abrahamsson, Meryl Dhir, Mats Fredrikson, Johnny Ludvigsson, Hans J. Arnqvist
Journal: Diabetes Care
Diabetes Care 2015;38(8):e124
https://doi.org/10.2337/dc15-0939
Published: 14 July 2015
View articletitled, Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315
Open the PDF for Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315 in another window
Journal Articles

Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)

Maria Nordwall, Mariann Abrahamsson, Meryl Dhir, Mats Fredrikson, Johnny Ludvigsson, Hans J. Arnqvist
Journal: Diabetes Care
Diabetes Care 2015;38(2):308–315
https://doi.org/10.2337/dc14-1203
Published: 15 December 2014
View articletitled, Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)
Open the PDF for Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden) in another window
Includes: Supplementary data
Journal Articles

Response to Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test: Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Diabetes Care 2013;36:195–201

Beverley M. Shields, PHD, William Henley, PHD, Rachel E.J. Besser, PHD, Andrew T. Hattersley, DM, Johnny Ludvigsson, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(12):e222
https://doi.org/10.2337/dc13-0609
Published: 13 November 2013
View articletitled, Response to Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test: Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Diabetes Care 2013;36:195–201
Open the PDF for Response to Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test: Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Diabetes Care 2013;36:195–201 in another window
Includes: Supplementary data
Journal Articles

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial

Stina Axelsson, PHD, Mikael Chéramy, PHD, Linda Åkerman, MSC, Mikael Pihl, MSC, Johnny Ludvigsson, MD, PHD, Rosaura Casas, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(11):3418–3424
https://doi.org/10.2337/dc12-2251
Published: 15 October 2013
View articletitled, Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
Open the PDF for Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial in another window
Includes: Supplementary data
Journal Articles

Early Electrophysiological Abnormalities and Clinical Neuropathy: A prospective study in patients with type 1 diabetes

Lars Hyllienmark, MD, Nils Alstrand, MD, Björn Jonsson, PHD, Johnny Ludvigsson, MD, Gerald Cooray, MD, Jeanette Wahlberg-Topp, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3187–3194
https://doi.org/10.2337/dc12-2226
Published: 14 September 2013
View articletitled, Early Electrophysiological Abnormalities and Clinical Neuropathy: A prospective study in patients with type 1 diabetes
Open the PDF for Early Electrophysiological Abnormalities and Clinical Neuropathy: A prospective study in patients with type 1 diabetes in another window
Journal Articles

A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease

Kaziwe Mollazadegan, MD, Maria Kugelberg, MD, Scott M. Montgomery, PHD, David S. Sanders, MB, Johnny Ludvigsson, MD, Jonas F. Ludvigsson, MD
Journal: Diabetes Care
Diabetes Care 2013;36(2):316–321
https://doi.org/10.2337/dc12-0766
Published: 17 January 2013
View articletitled, A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
Open the PDF for A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease in another window
Includes: Supplementary data
Journal Articles

Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes

Rachel E.J. Besser, PHD, Beverley M. Shields, PHD, Rosaura Casas, PHD, Andrew T. Hattersley, DM, Johnny Ludvigsson, MD
Journal: Diabetes Care
Diabetes Care 2013;36(2):195–201
https://doi.org/10.2337/dc12-0836
Published: 17 January 2013
View articletitled, Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes
Open the PDF for Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes in another window
Includes: Supplementary data
Journal Articles

Breast-Feeding and Childhood-Onset Type 1 Diabetes: A pooled analysis of individual participant data from 43 observational studies

Chris R. Cardwell, PHD, Lars C. Stene, PHD, Johnny Ludvigsson, MD, Joachim Rosenbauer, MD, Ondrej Cinek, MD, Jannet Svensson, PHD, Francisco Perez-Bravo, PHD, Anjum Memon, MBBS, Suely G. Gimeno, DPH, Emma J.K. Wadsworth, PHD, Elsa S. Strotmeyer, PHD, Michael J. Goldacre, FFPHM, Katja Radon, PHD, Lee-Ming Chuang, MD, Roger C. Parslow, PHD, Amanda Chetwynd, PHD, Kyriaki Karavanaki, MD, Girts Brigis, MD, Paolo Pozzilli, MBBS, Brone UrbonaitĖ, MD, Edith Schober, MD, Gabriele Devoti, MD, Sandra Sipetic, MD, Geir Joner, MD, Constantin Ionescu-Tirgoviste, MD, Carine E. de Beaufort, MD, Kirsten Harrild, MSC, Victoria Benson, PHD, Erkki Savilahti, MD, Anne-Louise Ponsonby, MBBS, Mona Salem, MD, Samira Rabiei, MSC, Chris C. Patterson, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(11):2215–2225
https://doi.org/10.2337/dc12-0438
Published: 13 October 2012
View articletitled, Breast-Feeding and Childhood-Onset Type 1 Diabetes: A pooled analysis of individual participant data from 43 observational studies
Open the PDF for Breast-Feeding and Childhood-Onset Type 1 Diabetes: A pooled analysis of individual participant data from 43 observational studies in another window
Includes: Supplementary data
Journal Articles

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes

Rachel E.J. Besser, MBBS, Johnny Ludvigsson, PHD, Angus G. Jones, MBBS, Timothy J. McDonald, MSC, Beverley M. Shields, PHD, Bridget A. Knight, PHD, Andrew T. Hattersley, DM
Journal: Diabetes Care
Diabetes Care 2011;34(3):607–609
https://doi.org/10.2337/dc10-2114
Published: 17 February 2011
View articletitled, Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
Open the PDF for Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

Carla J. Greenbaum, MD, Thomas Mandrup-Poulsen, MD, PHD, Paula Friedenberg McGee, MS, Tadej Battelino, MD, PHD, Burkhard Haastert, PHD, Johnny Ludvigsson, MD, PHD, Paolo Pozzilli, MD, PHD, John M. Lachin, SCD, Hubert Kolb, MD, PHD, The Type 1 Diabetes Trial Net Research Group and the European C-Peptide Trial Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(10):1966–1971
https://doi.org/10.2337/dc07-2451
Published: 01 October 2008
View articletitled, Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Open the PDF for Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes in another window
Includes: Supplementary data